Also trades as: 0I5P.L (LSE) · $vol 0M
CBAY NASDAQ
CymaBay Therapeutics, Inc.
1W: +0.1%
1M: +0.8%
3M: +46.2%
1Y: +262.9%
3Y: +579.5%
5Y: +172.2%
$32.48
Last traded 2024-03-25 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$31M
Revenue
+0.0% YoY
$-112M
Net Income
+11.0% YoY
$-73M
Free Cash Flow
+13.4% YoY
1.8%
Gross Margin
-74557.9%
Op. Margin
-73512.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-68.0%
ROA-38.7%
ROIC-642.9%
Valuation
P/E-32.8
P/B11.8
EV/EBITDA-25.1
Leverage
Debt/Equity0.39
Current Ratio10.96
Interest Cov.-5.1x
Quality Scores
Piotroski F5/9
Altman Z8.48
Beneish M0.00